William Roach will share how to apply Adimab's diverse tools for novel T cell engagers.
Garrett Rappazzo will present on Adimab's approach to pHLA-targeting therapeutics.
Emily Radke will share a poster on Adimab's HCAb CD3 binders.
Adimab will be available for partnering meetings to discuss new and ongoing projects.
The Adimab team will present on TCEs, developability, peptides, and more as they take the stage and chair sessions.
Arvind Sivasubramanian will present on specificity profiling at Adimab.
